NewsBenzingaGlucotrack Subsidiary Lōkahi Therapeutics Engaged Two ai² PIPELINE Project Teams To Identify And Evaluate Brain Tumor Therapeutic Assets Available For Licensing And Development Glucotrack Subsidiary Lōkahi Therapeutics Engaged Two ai² PIPELINE Project Teams To Identify And Evaluate Brain Tumor Therapeutic Assets Available For Licensing And Development Benzinga 2026.09.23 20:32 (GMT+0) Open on Benzinga Other news Exelon: Shelter From The Storm And Nice Yield As Utilities Catch A Bid (NASDAQ:EXC) NVIDIA GTC Berlin kicks off October 20, Jensen Huang to deliver keynote on October 21 Here's What to Expect From Apollo Global Management's Next Earnings Report South Korea's FSS to Build Crypto Asset Regulatory Framework with FIU JD.com: China's Sluggish Domestic Consumption May Render It A Value Trap (NASDAQ:JD) What Would Stop The AI Sell-Off (NASDAQ:SMH)
